J. Strohalm

K. Ulbrich, V. Šubr, Martin Strohalm, 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Abnormal differentiation of thymocytes induced by free cyclosporine is avoided when cyclosporine bound to N-(2-hydroxypropyl)methacrylamide copolymer carrier is used.

K. Ulbrich, B. Říhová, P. Rossmann, 1997, Transplantation.

Effect of pre-immunisation on the activity of polymer-doxorubicin against murine L1210 leukaemia

K. Ulbrich, R. Duncan, J. Strohalm, 1993 .

Anti-Lymphoma Efficacy Comparison of Anti-CD20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates

T. Etrych, O. Janoušková, J. Strohalm, 2015, Molecules.

Induction of Systemic Antitumour Resistance with Targeted Polymers

K. Ulbrich, V. Šubr, T. Mrkvan, 2005, Scandinavian journal of immunology.

In Vitro and In Vivo Effect of HPMA Copolymer-bound Doxorubicin Targeted to Transferrin Receptor of B-cell Lymphoma 38C13

K. Ulbrich, B. Říhová, J. Strohalm, 2002, Journal of drug targeting.

A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier.

K. Ulbrich, B. Říhová, J. Strohalm, 1999, European journal of cancer.

Decreased Binding to Proteins and Cells of Polymeric Gene Delivery Vectors Surface Modified with a Multivalent Hydrophilic Polymer and Retargeting through Attachment of Transferrin*

K. Ulbrich, V. Šubr, M. Wolfert, 2000, The Journal of Biological Chemistry.

Antitumor activity of IL‐2/anti‐IL‐2 mAb immunocomplexes exerts synergism with that of N‐(2‐hydroxypropyl)methacrylamide copolymer‐bound doxorubicin conjugate due to its low immunosuppressive activity

K. Ulbrich, B. Říhová, M. Šírová, 2011, International journal of cancer.

Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.

K. Ulbrich, A. Perkins, R. Duncan, 1996, Journal of drug targeting.

Polymeric carriers of drugs for site‐specific therapy

K. Ulbrich, V. Šubr, B. Říhová, 1997 .

Gamma Scintigraphy of the Biodistribution of 123I-Labelled N-(2-Hydroxypropyl)methacrylamide Copolymer-Doxorubicin Conjugates in Mice with Transplanted Melanoma and Mammary Carcinoma

K. Ulbrich, A. Perkins, R. Duncan, 1996 .

Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA.

K. Ulbrich, M. Wolfert, S. Smart, 1999, Bioconjugate chemistry.

Biodegradable drug carriers based on poly(ethylene glycol) block copolymers

K. Ulbrich, E. Schacht, J. Strohalm, 1997 .

SYNTHESIS OF POLY(ETHYLENE GLYCOL) BLOCK COPOLYMERS AS POTENTIAL WATER-SOLUBLE DRUG CARRIERS

K. Ulbrich, J. Strohalm, M. Pechar, 1995 .

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs.

K. Ulbrich, B. Říhová, O. Hovorka, 2002, Journal of controlled release : official journal of the Controlled Release Society.

HPMA copolymer-bound doxorubicin targeted to tumor-specific antigen of BCL1 mouse B cell leukemia.

K. Ulbrich, T. Etrych, T. Mrkvan, 2003, Journal of controlled release : official journal of the Controlled Release Society.

Synthesis of Biodegradable Polymers for Controlled Drug Release a

K. Ulbrich, V. Šubr, B. Říhová, 1997, Annals of the New York Academy of Sciences.

Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of methotrexate: Synthesis and in vitro drug release

K. Ulbrich, V. Šubr, J. Strohalm, 1997 .

Intraperitoneal and subcutaneous retention of a soluble polymeric drug-carrier bearing galactose

K. Ulbrich, J. Kopeček, R. Duncan, 1991 .

iBodies: Modular Synthetic Antibody Mimetics Based on Hydrophilic Polymers Decorated with Functional Moieties

K. Ulbrich, V. Šubr, J. Konvalinka, 2016, Angewandte Chemie.

Doxorubicin attached to HPMA copolymer via amide bond modifies the glycosylation pattern of EL4 cells

K. Ulbrich, V. Šubr, L. Kovář, 2010, Tumor Biology.

Synthesis of poly[N-(2-hydroxypropyl)methacrylamide] conjugates of inhibitors of the ABC transporter that overcome multidrug resistance in doxorubicin-resistant P388 cells in vitro.

K. Ulbrich, V. Šubr, B. Říhová, 2014, Biomacromolecules.

Polymers containing enzymatically degradable bonds, XII. Effect of spacer structure on the rate of release of daunomycin and adriamycin from poly [N-(2-hydroxypropyl)-methacrylamide] copolymer drag carriers in vitro and antitumour activity measured in vivo

K. Ulbrich, V. Šubr, R. Duncan, 1992 .

HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.

K. Ulbrich, L. Kovář, T. Etrych, 2009, Journal of controlled release : official journal of the Controlled Release Society.

N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice.

K. Ulbrich, S. Wedge, R. Duncan, 1991, British Journal of Cancer.

Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.

J. Kopeček, R. Duncan, L. Seymour, 1987, Journal of biomedical materials research.

Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody.

V. Vetvicka, B. Říhová, J. Kopeček, 1988, Clinical immunology and immunopathology.

Poly[N-(2-hydroxypropyl)methacrylamide]-based tissue-embedding medium compatible with MALDI mass spectrometry imaging experiments.

K. Ulbrich, Martin Strohalm, V. Havlíček, 2011, Analytical chemistry.

Polymer-conjugated bovine pancreatic and seminal ribonucleases inhibit growth of human tumors in nude mice.

K. Ulbrich, M. Zadinová, P. Poučková, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Poly [N -(2-hydroxypropyl)methacrylamide] Conjugates of Bovine Pancreatic Ribonuclease (RNase A) Inhibit Growth of Human Melanoma in Nude Mice

K. Ulbrich, M. Zadinová, P. Poučková, 2002, Journal of drug targeting.

Polymer conjugated bovine seminal ribonuclease inhibits growth of solid tumors and development of metastases in mice.

K. Ulbrich, M. Zadinová, P. Poučková, 2001, Neoplasma.

Differences in the intracellular fate of free and polymer-bound doxorubicin.

K. Ulbrich, V. Šubr, T. Etrych, 2002, Journal of controlled release : official journal of the Controlled Release Society.

Chemotherapy based on HPMA copolymer conjugates with pH-controlled release of doxorubicin triggers anti-tumor immunity.

K. Ulbrich, T. Etrych, T. Mrkvan, 2005, Journal of controlled release : official journal of the Controlled Release Society.

Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier.

K. Ulbrich, H. Maeda, R. Duncan, 1995, European journal of cancer.

The structure-dependent toxicity, pharmacokinetics and anti-tumour activity of HPMA copolymer conjugates in the treatment of solid tumours and leukaemia.

K. Ulbrich, T. Etrych, B. Říhová, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Osmotic opening of the blood-brain barrier permeability to N-(2-hydroxypropyl)methacrylamide copolymers. Effect of polymer -Mw charge and hydrophobicity

S. Rapoport, J. Kopeček, R. Duncan, 1989 .

HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.

K. Ulbrich, L. Kovář, T. Etrych, 2013, Current medicinal chemistry.

Immunoprotective therapy with targeted anticancer drugs

K. Ulbrich, E. Schacht, B. Říhová, 2001 .

Cytotoxic and Immunomodulatory Activites of Polymer-Bound Drugs

K. Ulbrich, V. Šubr, T. Etrych, 2004 .

Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene.

K. Ulbrich, B. Říhová, O. Hovorka, 2000, Bioconjugate chemistry.

Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting.

K. Ulbrich, T. Etrych, J. Strohalm, 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Starlike vs. Classic Macromolecular Prodrugs: Two Different Antibody-Targeted HPMA Copolymers of Doxorubicin Studied in Vitro and in Vivo as Potential Anticancer Drugs

Markéta Jelínková, K. Ulbrich, T. Etrych, 2003, Pharmaceutical Research.

Polymeric conjugates of drugs and antibodies for site‐specific drug delivery

K. Ulbrich, V. Šubr, B. Říhová, 1996 .

Hydrophilic polymers for drug delivery

K. Ulbrich, V. Šubr, B. Říhová, 2000 .

Poly[N-(2-hydroxypropyl)methacrylamide]-based tissue-embedding medium compatible with MALDI mass spectrometry imaging experiments.

K. Ulbrich, Martin Strohalm, V. Havlíček, 2011, Analytical chemistry.

Synthesis of Well-Defined Semitelechelic Poly[N-(2-hydroxypropyl)methacrylamide] Polymers with Functional Group at the α-End of the Polymer Chain by RAFT Polymerization

K. Ulbrich, V. Šubr, T. Etrych, 2013 .

HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.

K. Ulbrich, L. Kovář, T. Etrych, 2009, Journal of controlled release : official journal of the Controlled Release Society.